NEU 2.32% $13.24 neuren pharmaceuticals limited

Importance of the trial results & challenges, page-5

  1. 14,954 Posts.
    lightbulb Created with Sketch. 696
    Yes that's what l believe many are missing it's no coincidence we have the autism patent. We have unlocked something very significant across other neuro disorders as Mr Kaufmann says,

    The impact of the study goes
    beyond the suggested efficacy of trofinetide, since it shows the potential of neurobiologically-based drugs for the treatment of Rett syndrome and other neurodevelopmental disorders."
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.